CENCORA
LIVE

Serial Number

97765170

Owner

Cencora, Inc.

Attorney

Anita B. Polott

Filing Date

Jan 23, 2023

Add to watchlist:

No watchlists yet
View on USPTO

CENCORA Trademark

Serial Number: 97765170

CENCORA is a trademark filed by Cencora, Inc. on January 23, 2023. The trademark is classified under Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Cencora, Inc. (74 trademarks)

1 West First Avenue
Conshohocken, PA 19428

Entity Type: 03

AmerisourceBergen Corporation (57 trademarks)

1 West First Avenue
Conshohocken, PA 19428

Entity Type: 03

Trademark Details

Filing Date

January 23, 2023

Registration Date

Not Registered

Published for Opposition

December 3, 2024

Goods & Services

Medical analysis services, namely, medical diagnostic testing, monitoring and reporting in the field of human disease treatment; providing medical information being a secured-access internet website for medical professionals and medical patients featuring medical information and analysis of patient data in the field of oncology care practices being the specific diagnosis, line of therapy, stage of disease and regimen information; providing clinical and home health care services, namely, providing medical and healthcare information relating to therapeutic properties of pharmaceuticals; providing medical counseling and healthcare counseling being health counseling to patients in the field of administration of medications; providing medical clinic and health clinic services; home health care services; providing medical care information being medical information; Health care services, namely, providing wellness programs for disease treatment and management featuring patient-centered incentives for compliance with physician-directed educational, medication therapy, and home care programs; providing medical, health and veterinary information services for the pharmaceutical and medical sectors; providing medical information services in the field of diagnostic, prophylactic and therapeutic properties of pharmaceuticals for the pharmaceutical and medical sectors; providing medical and health counseling and pharmaceutical advice services related to workplace and personnel health; healthcare services; providing medical and healthcare information on medical substances; medical and healthcare consulting being consultancy services relating to medical care and health care in the field of analyzing and reporting of discussions about human disease treatment; medical services being administration and management of sophisticated pharmaceutical therapies; providing medical information, health information, veterinary information, pharmaceutical advice and biotechnical information being healthcare information via a website; remote healthcare and telemedicine services being healthcare services provided via telecommunication in the nature of remote monitoring of data indicative of the health or condition of a patient for medical treatment purposes; remote healthcare and telemedicine services being providing patients with health information relating to their medical condition; beauty consultancy and health care consulting services; providing nursing services to others on behalf of pharmaceutical and biotechnology companies; providing health and nutrition information in the field of animal management; medical consulting, healthcare consulting, and veterinary consulting services in the field of animal, medical and healthcare management, and in the field of research, development, analysis and identification of processes to efficiently raise individual animals

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 14, 2026 EXRA
SOU EXTENSION 2 GRANTED
Jan 13, 2026 EX2G
SOU EXTENSION 2 FILED
Jan 13, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 13, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 11, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jul 10, 2025 EX1G
SOU EXTENSION 1 FILED
Jul 10, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 10, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 14, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 3, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 3, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 27, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 11, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 11, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 11, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 11, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 11, 2024 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 5, 2024 GNFN
FINAL REFUSAL E-MAILED
Sep 5, 2024 GNFR
FINAL REFUSAL WRITTEN
Sep 5, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 18, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 18, 2024 TROA
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Apr 18, 2024 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Apr 18, 2024 PARI
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 16, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 16, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 19, 2023 GNRN
NON-FINAL ACTION E-MAILED
Oct 19, 2023 GNRT
NON-FINAL ACTION WRITTEN
Oct 19, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 19, 2023 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 18, 2023 ASGN
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jul 21, 2023 AMPX
ASSIGNED TO LIE
Jul 21, 2023 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Jul 14, 2023 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 13, 2023 NWOS
NEW APPLICATION ENTERED
Jan 26, 2023 NWAP